Optimizing MRI scan time in the computation of pharmacokinetic parameters (Ktrans) in breast cancer diagnosis

Journal of Magnetic Resonance Imaging

Volumn 38, Issue 3, 2013, Pages 573-579

  Jena, Amarnath ^a   Mehta, Shashi Bhushan ^a   Taneja, Sangeeta ^a  

^a RAJIV GANDHI CANCER INSTITUTE AND RESEARCH CENTRE   (India)

Author keywords

acquisition time; DCE MRI; Ktrans; pharmacokinetic parameters

Indexed keywords

GADODIAMIDE;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BREAST; BREAST CANCER; BREAST CARCINOMA; CALCULATION; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL PROTOCOL; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG BLOOD LEVEL; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE QUALITY; IMAGE RECONSTRUCTION; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PHARMACOLOGICAL PARAMETERS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUMOR VOLUME;

ACQUISITION TIME; DCE-MRI; KTRANS; PHARMACOKINETIC PARAMETERS;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; BREAST NEOPLASMS; COMPUTER SIMULATION; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; METABOLIC CLEARANCE RATE; MIDDLE AGED; MODELS, BIOLOGICAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84883343396     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.24008     Document Type: Article

References (25)

1. Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999; 211: 101-110.
2. Hittmair K, Gomiscek G, Langenberger K, Recht M, Imhof H, Kramer J,. Method for the quantitative assessment of contrast agent uptake in dynamic contrast-enhanced MRI. Magn Reson Med 1994; 31: 567-571.
3. Kovar DA, Lewis M, Karczmar GS,. A new method for imaging perfusion and contrast extraction fraction: input functions derived from reference tissues. J Magn Reson Imaging 1998; 8: 1126-1134.
4. Den Boer JA, Hoendrop RKKM, Smink J, et al. Pharmacokinetic analysis of Gd-DTPA enhancement in dynamic three-dimensional MRI of breast lesions. J Magn Reson Imaging 1997; 7: 702-715.
5. Hoffmann U, Brix G, Knopp MV, Hess T, Lorenz WJ,. Pharmacokinetic mapping of the breast: a new method for dynamic mr mammography. Magn Reson Med 1995; 33: 506-514.
6. Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T1-Weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10: 223-232.
7. Tofts PS,. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997; 7: 91-101.
8. Mark AH, Bruno M,. Algorithms for calculation of kinetic parameters from T1-weighted dynamic contrast-enhanced magnetic resonance imaging. J Magn Reson Imaging 2004; 20: 723-729.
9. Kim JK, Hong SS, Choi YJ, et al. Wash-in rate on the basis of dynamic contrast-enhanced MRI: usefulness for prostate cancer detection and localization. J Magn Reson Imaging 2005; 22: 639-646.
10. Gibbs P, Liney GP, Lowry M, Kneeshaw PJ, Turnbull LW,. Differentiation of benign and malignant sub-1 cm breast lesions using dynamic contrast enhanced MRI. Breast 2004; 13: 115-121.
11. Jansen A, Fan X, Karczmar GS, Abe H, Schmidt R, Newstead GM,. Differentiation between benign and malignant breast lesions detected by bilateral dynamic contrast enhanced MRI: a sensitivity and specificity study. Magn Reson Med 2008; 59: 747-754.
12. Liu F, Kornecki A, Shmuilovich O, Gelman N,. Optimization of time-to-peak analysis for differentiating malignant and benign breast lesions with dynamic contrast enhanced MRI. Acad Radiol 2011; 18: 694-704.
13. Weidner N, Semple JP, Welch WR, Folkman J,. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
14. Taylor JS, Tofts PS, Port R, et al. MR imaging of tumor microcirculation: promise for the new millennium. J Magn Reson Imaging 1999; 10: 903-907.
15. Hansen S, Grabau DA, Sorensen FB, Bak M, Vach W, Rose C,. Vascular grading of angiogenesis: prognostic significance in breast cancer. Br J Cancer 2000; 82: 339-347.
16. Su MY, Cheung YC, Fruehauf JP, et al. Correlation of dynamic contrast enhancement MRI parameters with microvessel density and VEGF for assessment of angiogenesis in breast cancer. J Magn Reson Imaging 2003; 18: 467-477.
17. Henderson E, Rutt BK, Lee TY, Temporal sampling requirements for the tracer kinetics modeling of breast disease, Magn Reson Imaging 1998; 16: 1057-1073.
18. Cao Y, Li D, Shen Z, Normolle D,. Sensitivity of quantitative metrics derived from DCE MRI and a pharmacokinetic model to image quality and acquisition parameters. Acad Radiol 2010; 17: 468-478.
19. Wang Y, Huang W, Panicek DM, Schwartz LH, Koutcher JA,. Quantitative 0steosarcoma DCE-MRI: How long is the acquisition time necessary, session: tumor perfusion & permeability. In: Proc ISMRM, Stockholm; 2010 (abstract 18).
20. Jaspers K, Aerts HJWL, Leiner T, et al. Reliability of pharmacokinetic parameters: small vs. Medium-sized contrast agents. Magn Reson Med 2009; 62: 779-787.
21. Veltman J, Stoutjesdijk M, Mann R, et al. Contrast-enhanced magnetic resonance imaging of the breast: the value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in classifying lesions. Eur Radiol 2008; 18: 1123-1133.
22. Rueckert D, Sonoda LI, Hayes C, Hill DLG, Leach MO, Hawkes DJ,. Nonrigid registration using free-form deformations: application to breast MR images. IEEE Trans Med Imaging 1999; 18: 712-721.
23. Thijsse BJ, Hollanders MA, Hendrikse J,. A practical algorithm for least-squares spline approximation of data containing noise. Comput Phys 1998; 12: 393-399.
24. Huisman HJ, Engelbrecht MR, Barentsz JO,. Accurate estimation of pharmacokinetic contrast enhanced dynamic MRI parameters of the prostate. J Magn Reson Imaging 2001; 13: 607-614
25. Tofts PS, Kermode AG,. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. Fundamental Concepts. Magn Reson Med 1991; 17: 357-367.